Noel J. Cusack - Concepedia

Author

Noel J. Cusack

Also Known As

N Cusack, N J Cusack, N. Cusack, N. J. CUSACK, N. J. Cusack, N.J. CUSACK, N.J. Cusack, NOEL J. CUSACK, Noel Cusack, Noel J Cusack

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

King's College London University of London University of Cambridge King's College Hospital University College London

About

Noel J. Cusack is an author at King's College London specializing in pharmacology, biochemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	801
2	Natural Sciences	8	8	422
3	Engineering	6	6	148
4	Health Sciences	2	2	80
5	Social Sciences	1	1	30

Noel J. Cusack

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Regulation of P<sub>2y</sub>‐purinoceptor‐mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration Trevor J. Hallam, Noel J. Cusack, Jeremy D. Pearson British Journal of Pharmacology	1988	141
Characteristics of the P2 purinoceptor that mediates prostacyclin production by pig aortic endothelial cells Lindsey Needham, Noel J. Cusack, Jeremy D. Pearson, European Journal of Pharmacology Molecular PharmacologyP2 PurinoceptorMolecular PhysiologySignal TransductionProstacyclin Production	1987	140
2,4,6-Tri-isopropylbenzenesulphonyl hydrazide: A convenient source of di-imide Noel J. Cusack, Colin B. Reese, A. C. RISIUS, Tetrahedron Derivative (Chemistry)Organic Chemistry2,4,6-Tri-isopropylbenzenesulphonyl HydrazideChemistryPharmacology	1976	133
The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency Laurence A. Welford, Noel J. Cusack, Susanna M.O. Hourani European Journal of Pharmacology BiochemistryMedicineExcitatory P2-purinoceptorsStructure-activity RelationshipsNeuropharmacology	1987	130
ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor Laurence A. Welford, Noel J. Cusack, Susanna M.O. Hourani European Journal of Pharmacology Cellular EnzymologyBiochemistryNatural SciencesStructure-activity RelationshipsMolecular Biology	1986	123
Specificity of P2-purinoceptor that mediates endothelium-dependent relaxation of the pig aorta William Martin, Noel J. Cusack, J. Susan Carleton, European Journal of Pharmacology Animal PhysiologyMolecular PharmacologyMolecular PhysiologyMedicineVascular Pharmacology	1985	113
Characterisation of the ATP4− receptor that mediates permeabilisation or rat mast cells Peter E.R. Tatham, Noel J. Cusack, Bastien D. Gomperts European Journal of Pharmacology Molecular PhysiologySignal TransductionBiochemistryCell SignalingNatural Sciences	1988	98
Stereoselectivity of ectonucleotidases on vascular endothelial cells Noel J. Cusack, Jeremy D. Pearson, John L. Gordon Biochemical Journal	1983	98
ADENOSINE 5′‐DIPHOSPHATE ANTAGONISTS AND HUMAN PLATELETS: NO EVIDENCE THAT AGGREGATION AND INHIBITION OF STIMULATED ADENYLATE CYCLASE ARE MEDIATED BY DIFFERENT RECEPTORS Noel J. Cusack, S.M.O. Hourani British Journal of Pharmacology	1982	87
Studies on the stereoselectivity of the P<sub>2</sub>‐purinoceptor Geoffrey Burnstock, Noel J. Cusack, J.M. Hills, British Journal of Pharmacology	1983	81

Page 1